Bio-Connect
Immunohistochemical staining of formalin fixed and paraffin embedded human thymus using Anti-CD28 Rabbit Monoclonal Antibody (Clone RM404) at a 1:200 dilution.
Immunohistochemical staining of formalin fixed and paraffin embedded human thymus using Anti-CD28 Rabbit Monoclonal Antibody (Clone RM404) at a 1:200 dilution.
Immunohistochemical staining of formalin fixed and paraffin embedded human thymus using Anti-CD28 Rabbit Monoclonal Antibody (Clone RM404) at a 1:200 dilution.

anti-MSH3 (human), Rabbit Monoclonal (RM405)

REV-31-1291-00
RevMAb Biosciences
ApplicationsWestern Blot, ImmunoHistoChemistry
Product group Antibodies
TargetMSH3
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    RevMAb Biosciences
  • Product Name
    anti-MSH3 (human), Rabbit Monoclonal (RM405)
  • Delivery Days Customer
    10
  • Applications
    Western Blot, ImmunoHistoChemistry
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    RM405
  • Gene ID4437
  • Target name
    MSH3
  • Target description
    mutS homolog 3
  • Target synonyms
    divergent upstream protein; DNA mismatch repair protein Msh3; DUP; epididymis secretory sperm binding protein; FAP4; hMSH3; mismatch repair protein 1; MRP1
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP20585
  • Protein Name
    DNA mismatch repair protein Msh3
  • Scientific Description
    Recombinant Antibody. This antibody reacts to human to MSH3. Applications: WB, IHC. Source: Rabbit. Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide. The mismatch repair (MMR) proteins are required to maintain genomic integrity in prokaryotes and eukaryotes, by correcting single mismatches and short unpaired regions, such as small insertions and deletions. In eukaryotes, three proteins are involved in mismatch recognition, MSH2, MSH3 and MSH6. The three proteins form two heterodimers MutSalpha (MSH2-MSH6) and MutSbeta (MSH2-MSH3). MutSalpha is thought to be involved primarily in the recognition and repair of base-base mismatches and small insertion/deletion loops. MutSbeta acts preferentially on insertion/deletion loops up to 12 nucleotides in length. The MSH2, MSH3, and PMS2 mismatch repair proteins are also involved in other DNA repair pathways such as single-strand annealing and homologous recombination, anti-recombination, DNA damage signaling, apoptosis, as well as site-specific mutagenesis during immunoglobin somatic hypermutation and class switch recombination. They interact with several other oncogenic targets, including ATR, BRCA1 or p53. Deficiencies in expression of DNA repair genes underlie many forms of cancer. If DNA repair is deficient, DNA damage tends to accumulate. Such excess DNA damage may increase mutations due to error-prone translesion synthesis and error prone repair. Elevated DNA damage may also increase epigenetic alterations due to errors during DNA repair. Such mutations and epigenetic alterations may give rise to cancer. Loss of MSH3 can lead to mismatch repair deficiency and genetic instability which have been identified as particularly common carcinogenic effects in human colorectal cancer. Mutations causing MSH3 knockdown can lead to diminished capacity for cells to repair long insertion/deletion loops causing microsatellite instabilities (MSI) in the genome and allowing an increase in the rates of somatic mutation. - The mismatch repair (MMR) proteins are required to maintain genomic integrity in prokaryotes and eukaryotes, by correcting single mismatches and short unpaired regions, such as small insertions and deletions. In eukaryotes, three proteins are involved in mismatch recognition, MSH2, MSH3 and MSH6. The three proteins form two heterodimers MutSalpha (MSH2-MSH6) and MutSbeta (MSH2-MSH3). MutSalpha is thought to be involved primarily in the recognition and repair of base-base mismatches and small insertion/deletion loops. MutSbeta acts preferentially on insertion/deletion loops up to 12 nucleotides in length. The MSH2, MSH3, and PMS2 mismatch repair proteins are also involved in other DNA repair pathways such as single-strand annealing and homologous recombination, anti-recombination, DNA damage signaling, apoptosis, as well as site-specific mutagenesis during immunoglobin somatic hypermutation and class switch recombination. They interact with several other oncogenic targets, including ATR, BRCA1 or p53. Deficiencies in expression of DNA repair genes underlie many forms of cancer. If DNA repair is deficient, DNA damage tends to accumulate. Such excess DNA damage may increase mutations due to error-prone translesion synthesis and error prone repair. Elevated DNA damage may also increase epigenetic alterations due to errors during DNA repair. Such mutations and epigenetic alterations may give rise to cancer. Loss of MSH3 can lead to mismatch repair deficiency and genetic instability which have been identified as particularly common carcinogenic effects in human colorectal cancer. Mutations causing MSH3 knockdown can lead to diminished capacity for cells to repair long insertion/deletion loops causing microsatellite instabilities (MSI) in the genome and allowing an increase in the rates of somatic mutation.
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

Related products

Product group Antibodies
Assay Genie
TargetMSH3
  • SizePrice
Product group Antibodies
GeneTex
ApplicationsWestern Blot
TargetMSH3
  • SizePrice
Western Blot analysis of HuvEc cells using MSH3 Polyclonal Antibody
Product group Antibodies
Cusabio
MSH3 AntibodyCSB-PA003320
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry
TargetMSH3
  • SizePrice
Product group Antibodies
Bethyl Laboratories
ApplicationsImmunoPrecipitation
TargetMSH3
  • SizePrice
Immunohistochemical staining of human cervical cancer shows strong nuclear positivity in tumor cells.
Product group Antibodies
Atlas Antibodies
ApplicationsWestern Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
TargetMSH3
  • SizePrice
Product group Antibodies
RayBiotech
ApplicationsWestern Blot
TargetMSH3
  • SizePrice
Figure 2. Immunohistochemistry validation of MSH3 using Anti-MSH3 (A80) Antibody (A02455). Immunohistochemistry (IHC) analyzes of MSH3 (A80) pAb in paraffin-embedded liver cancer tissue at 1:100. For more protocol information of IHC
Product group Antibodies
Boster Bio
ApplicationsWestern Blot, ImmunoHistoChemistry
TargetMSH3
  • SizePrice
Lane 1: Mouse Testis lysates; Lane 2: Human SW480 cell lysates probed with MSH3 Polyclonal Antibody, Unconjugated (bs-4919R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Product group Antibodies
Bioss Antibodies
ApplicationsImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
TargetMSH3
  • SizePrice
Product group Antibodies
LifeSpan BioSciences
MSH3 AntibodyLS-C334210
ApplicationsWestern Blot, ImmunoHistoChemistry
TargetMSH3
  • SizePrice
Anti-MSH3 (A80) Antibody
Product group Antibodies
Antibodies.com
ApplicationsWestern Blot, ImmunoHistoChemistry
  • SizePrice